Literature DB >> 17180354

Increased expression of CCAAT/enhancer binding protein-beta and -delta and monocyte chemoattractant protein-1 genes in aortas from hyperinsulinaemic rats.

Y Sato1, Y Nishio, O Sekine, K Kodama, Y Nagai, T Nakamura, H Maegawa, A Kashiwagi.   

Abstract

AIMS/HYPOTHESIS: We evaluated whether hyperinsulinaemia stimulates the expression of transcription factor CCAAT/enhancer binding protein (C/EBP)-beta and C/EBP-delta and leads to the induction of the chemokine (C-C motif) ligand 2 gene (Ccl2, also known as MCP-1) expression in aortas.
METHODS: Hyperinsulinaemia was induced by feeding rats a high-fructose diet. CCL2 production was analysed by ELISA. The expression of Ccl2, Cebpb and Cebpd mRNAs was investigated by quantitative RT-PCR. The binding of C/EBP-beta to Ccl2 was assessed by chromatin immunoprecipitation (ChIP) assay.
RESULTS: Insulin at a concentration of 10 nmol/l significantly stimulated the expression of Cebpb, Cebpd and Ccl2 mRNAs, depending on activation of phosphatidylinositol 3-kinase (PI3K) in cultured vascular smooth muscle cells. The knock-down of C/EBP-beta with siRNA abolished the insulin-induced Ccl2 mRNA expression. In the aortas from fructose-fed rats, the levels of phosphorylation of Akt/protein kinase B, a downstream effector of PI3K, were also increased. The expression of Cebpb, Cebpd and Ccl2 mRNAs in the aortas from fructose-fed rats were significantly elevated, by 330, 300 and 300%, respectively, compared with those of control-fed rats. The induction Ccl2 mRNA expression in the aortas was significantly correlated with the expression of Cebpb and Cebpd mRNAs in the aortas. Furthermore, the ChIP assay showed elevated binding of C/EBP-beta to the 5' upstream region of Ccl2 in the aortas from fructose-fed rats. CONCLUSIONS/
INTERPRETATION: These findings clearly indicate the role of C/EBPs in the mechanism of upregulation of CCL2, an inflammation-related protein, observed in the hyperinsulinaemic state, which may initiate the process of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17180354     DOI: 10.1007/s00125-006-0480-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  31 in total

Review 1.  Inflammation as a cardiovascular risk factor.

Authors:  James T Willerson; Paul M Ridker
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

Review 2.  The role of chemokines in human cardiovascular pathology: enhanced biological insights.

Authors:  William S Shin; Andrzej Szuba; Stanley G Rockson
Journal:  Atherosclerosis       Date:  2002-01       Impact factor: 5.162

Review 3.  The role of C/EBP isoforms in the control of inflammatory and native immunity functions.

Authors:  V Poli
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

4.  Insulin production in a neuroectodermal tumor that expresses islet factor-1, but not pancreatic-duodenal homeobox 1.

Authors:  T Nakamura; A Kishi; Y Nishio; H Maegawa; K Egawa; N C Wong; H Kojima; M Fujimiya; R Arai; A Kashiwagi; R Kikkawa
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

5.  Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity.

Authors:  A Ueda; Y Ishigatsubo; T Okubo; T Yoshimura
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

6.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

7.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma.

Authors:  Yasunori Takata; Yutaka Kitami; Zhao-Hui Yang; Michitsugu Nakamura; Takafumi Okura; Kunio Hiwada
Journal:  Circ Res       Date:  2002-09-06       Impact factor: 17.367

9.  Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation.

Authors:  Robert Kleemann; Philippe P Gervois; Lars Verschuren; Bart Staels; Hans M G Princen; Teake Kooistra
Journal:  Blood       Date:  2002-08-29       Impact factor: 22.113

10.  CCAAT/enhancer-binding protein decoy oligodeoxynucleotide inhibition of macrophage-rich vascular lesion formation in hypercholesterolemic rabbits.

Authors:  Ute Kelkenberg; Andreas H Wagner; Jasmin Sarhaddar; Markus Hecker; Heiko E von der Leyen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-06-01       Impact factor: 8.311

View more
  17 in total

1.  The involvement of cholesterol in sepsis and tolerance to lipopolysaccharide highlighted by the transcriptome analysis of zebrafish (Danio rerio).

Authors:  Sonia Dios; Pablo Balseiro; Maria M Costa; Alejandro Romero; Sebastián Boltaña; Nerea Roher; Simon Mackenzie; Antonio Figueras; Beatriz Novoa
Journal:  Zebrafish       Date:  2014-09-02       Impact factor: 1.985

2.  Reduction of ischemia-induced cerebral injury by all-trans-retinoic acid.

Authors:  Byung-Kwan Choi; Ji-Hoon Kim; Jong-Soo Jung; Young-Suk Lee; Myoung-Eun Han; Sun-Yong Baek; Bong-Seon Kim; Jae-Bong Kim; Sae-Ock Oh
Journal:  Exp Brain Res       Date:  2008-12-02       Impact factor: 1.972

3.  Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-kappaB and AP-1.

Authors:  Amy M Sutcliffe; Deborah L Clarke; Dawn A Bradbury; Lisa M Corbett; Jamie A Patel; Alan J Knox
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

4.  Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells.

Authors:  Niels Engberding; Alejandra San Martín; Abel Martin-Garrido; Mitsuhisa Koga; Lily Pounkova; Erin Lyons; Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-01-02       Impact factor: 8.311

5.  St. John's Wort protein, p27SJ, regulates the MCP-1 promoter.

Authors:  Ruma Mukerjee; Satish L Deshmane; Nune Darbinian; Marta Czernik; Kamel Khalili; Shohreh Amini; Bassel E Sawaya
Journal:  Mol Immunol       Date:  2008-07-22       Impact factor: 4.407

6.  Myocardin regulates vascular smooth muscle cell inflammatory activation and disease.

Authors:  Matthew Ackers-Johnson; Amarnath Talasila; Andrew P Sage; Xiaochun Long; Ilze Bot; Nicholas W Morrell; Martin R Bennett; Joseph M Miano; Sanjay Sinha
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-01-22       Impact factor: 8.311

7.  C/EBPβ promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer.

Authors:  Jiahong Tan; Xu Zheng; Mengchen Li; Fei Ye; Chunyan Song; Cheng Xu; Xiaoxue Zhang; Wenqian Li; Ya Wang; Shaoqing Zeng; Huayi Li; Gang Chen; Xiaoyuan Huang; Ding Ma; Dan Liu; Qinglei Gao
Journal:  Oncogene       Date:  2021-05-08       Impact factor: 9.867

8.  Biological roles of CCAAT/Enhancer-binding protein delta during inflammation.

Authors:  Chiung-Yuan Ko; Wen-Chang Chang; Ju-Ming Wang
Journal:  J Biomed Sci       Date:  2015-01-16       Impact factor: 8.410

9.  Understanding Haemophilus parasuis infection in porcine spleen through a transcriptomics approach.

Authors:  Hongbo Chen; Changchun Li; Mingdi Fang; Mengjin Zhu; Xinyun Li; Rui Zhou; Kui Li; Shuhong Zhao
Journal:  BMC Genomics       Date:  2009-02-05       Impact factor: 3.969

Review 10.  Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome.

Authors:  Eduardo Fuentes; Francisco Fuentes; Gemma Vilahur; Lina Badimon; Iván Palomo
Journal:  Mediators Inflamm       Date:  2013-06-13       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.